Azenta, Inc. (AZTA)

35.32 -2.18 (-5.81%) USD  |  NASDAQ  |  Dec 12, 16:00
35.32 0.00 (0.00%) After-Hours: 18:29
More

Azenta Research and Development Expense (Quarterly): 8.258M for Sept. 30, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for AZTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Bruker Corp. 98.30M
Harvard Bioscience, Inc. 2.132M
Precipio, Inc. --
Bionano Genomics, Inc. 2.844M
Kestra Medical Technologies Ltd. 4.001M